- Condition: Asthma
Interventions: Drug: Charcoal and Budesonide/formoterol Easyhaler 320/9 microg; Drug: Charcoal and Symbicort Turbuhaler; Drug: Budesonide/formoterol Easyhaler 320/9 microg; Drug: Symbicort Turbuhaler forte
Sponsors: Orion Corporation, Orion Pharma; Orion Corporation, Orion Pharma
Not yet recruiting - verified May 2012 - Conditions: Allergic Rhinitis; Rhinoconjunctivitis; Mild Persistent Asthma; Mild Intermittent Asthma
Intervention: Biological: Depigoid® (500 DPP/ml)
Sponsors: Laboratorios Leti, S.L.; Laboratorios Leti, S.L.; Harrison Clinical Research
Not yet recruiting - verified May 2012 - Conditions: Asthma, Aspirin-Induced; Aspirin Exacerbated Asthma
Intervention: Drug: Prasugrel
Sponsors: Brigham and Women's Hospital; Elliot Israel, MD; Brigham and Women's Hospital
Not yet recruiting - verified May 2012 - Condition: Asthma
Interventions: Drug: R940343; Drug: R940343; Drug: Placebo; Drug: Placebo
Sponsors: Rigel Pharmaceuticals; Rigel Pharmaceuticals
Not yet recruiting - verified May 2012 - Condition: Asthma
Intervention:
Sponsors: National Jewish Health; National Jewish Health; MedImmune LLC
Recruiting - verified April 2012 - Condition: Asthma
Intervention: Biological: Cohort 1
Sponsors: MedImmune LLC; MedImmune LLC
Not yet recruiting - verified May 2012 - Condition: Asthma
Interventions: Drug: Su-Huang antitussive capsule; Drug: Sugar pill
Sponsors: The First Affiliated Hospital of Guangzhou Medical University; The First Affiliated Hospital of Guangzhou Medical University
Not yet recruiting - verified April 2012 - Condition: Asthma
Interventions: Drug: beclomethasone+formoterol 50/6 (1 inhalation); Drug: CHF 1535 50/6 (2 inhalations); Drug: CHF 1535 50/6 (4 inhalations); Drug: Formoterol + Beclomethasone dipropionate; Drug: Placebo (6 inhalations)
Sponsors: Chiesi Farmaceutici S.p.A.; Chiesi Farmaceutici S.p.A.
Recruiting - verified April 2012 - Condition: Asthma
Intervention: Biological: Omalizumab
Sponsors: Instituto de Investigação em Imunologia; Instituto de Investigação em Imunologia
Not yet recruiting - verified April 2012 - Conditions: Asthma; Panic Disorder
Interventions: Behavioral: Music Relaxation Therapy (MRT); Behavioral: Cognitive Behavioral Therapy (CBT) and heart rate variability biofeedback
Sponsors: Albert Einstein College of Medicine of Yeshiva University; Albert Einstein College of Medicine of Yeshiva University; National Institute of Mental Health (NIMH)
Recruiting - verified April 2012 - Condition: Asthma
Interventions: Drug: MEMP1972A; Drug: MEMP1972A; Drug: MEMP1972A; Drug: placebo
Sponsors: Genentech; Genentech
Not yet recruiting - verified April 2012 - Condition: Asthma
Intervention: Drug: Magnesium Sulfate
Sponsors: Hamad Medical Corporation; Hamad Medical Corporation
Not yet recruiting - verified April 2012 - Condition: Asthma
Interventions: Drug: Albuterol 25 mcg, Placebo; Drug: Albuterol 0.25 mcg; Drug: Albuterol 90 mcg, Placebo; Drug: Albuterol, 90 mcg; Drug: Placebo; Drug: Proventil 90 mcg; Drug: Proventil 90 mcg
Sponsors: Amphastar Pharmaceuticals, Inc.; Amphastar Pharmaceuticals, Inc.
Recruiting - verified April 2012 - Condition: Asthma
Interventions: Drug: SB010; Drug: Placebo
Sponsors: Sterna Biologicals GmbH & Co. KG; Sterna Biologicals GmbH & Co. KG
Recruiting - verified April 2012 - Condition: Asthma
Interventions: Drug: Fluticasone propionate DPI Dose 1; Drug: Fluticasone propionate DPI Dose 2; Drug: Fluticasone propionate DPI Dose 3; Drug: Fluticasone propionate DPI Dose 4; Other: Placebo DPI; Drug: Flovent Diskus 250 mcg
Sponsors: Teva Pharmaceutical Industries; Teva Pharmaceutical Industries
Not yet recruiting - verified May 2012 - Conditions: Atopic Dermatitis; Eczema; Asthma; Food Allergies; Allergic Rhinitis
Intervention: Drug: Lipikar Balm AP
Sponsors: Cosmetique Active International; Cosmetique Active International; Innovaderm Research Inc.
Not yet recruiting - verified April 2012 - Condition: Asthma
Interventions: Drug: CHF1535 200/6 µg; Drug: BDP 100 µg
Sponsors: Chiesi Farmaceutici S.p.A.; Chiesi Farmaceutici S.p.A.
Not yet recruiting - verified April 2012 - Condition: Asthma
Interventions: Drug: FF/GSK573719; Drug: FF/GSK573719; Drug: FF/GSK573719; Drug: FF/GSK573719; Drug: FF/GSK573719; Drug: FF; Drug: FF/VI
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Recruiting - verified May 2012 - Condition: Rhinitis, Allergic, Perennial
Interventions: Drug: Montelukast to placebo; Drug: Placebo to montelukast
Sponsors: CHA University; CHA University; Merck
Not yet recruiting - verified March 2012 - Condition: Asthma
Intervention:
Sponsors: Chiesi Farmaceutici S.p.A.; Chiesi Farmaceutici S.p.A.
Not yet recruiting - verified March 2012 - Condition: Asthma
Interventions: Drug: Foster® NEXThaler® 100/6 µg/unit dose; Drug: Seretide® Accuhaler® 250/50 µg/actuation
Sponsors: Chiesi Farmaceutici S.p.A.; Chiesi Farmaceutici S.p.A.
Not yet recruiting - verified April 2012 - Condition: Asthma
Interventions: Drug: Mometasone Furoate/Formoterol Fumarate (MF/F) 100/5 mcg MDI; Drug: Mometasone Furoate/Formoterol Fumarate (MF/F) 200/5 mcg MDI
Sponsors: Schering-Plough; Schering-Plough
Recruiting - verified April 2012 - Condition: Asthma
Intervention: Procedure: Step-wise down-titration according to international guidelines.
Sponsors: Hospital Universitario Lucus Augusti; Luis Perez de Llano; Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau; Hospital Clinic of Barcelona; Hospital Galdakao-Usansolo; Complexo Hospitalario Universitario de A Coruña
Not yet recruiting - verified March 2012 - Condition: Asthma
Interventions: Drug: corticosteroid nasal spray; Drug: placebo nasal spray
Sponsors: St. Olavs Hospital; St. Olavs Hospital; Norwegian University of Science and Technology
Recruiting - verified March 2012 - Condition: Asthma
Interventions: Drug: ARRY-502, CRTh2 antagonist; oral; Drug: Placebo; oral
Sponsors: Array BioPharma; Array BioPharma
Recruiting - verified May 2012 - Condition: Asthma
Interventions: Drug: Fluticasone Furoate; Drug: Fluticasone Propionate; Drug: Placebo
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Not yet recruiting - verified March 2012 - Condition: Allergic Rhinoconjunctivitis
Interventions: Biological: Allergovac depot; Biological: Allergovac depot; Biological: Allergovac depot; Biological: Allergovac depot; Biological: Allergovac depot; Biological: Allergovac depot
Sponsors: BIAL Industrial Farmacéutica S.A.; BIAL Industrial Farmacéutica S.A.
Not yet recruiting - verified March 2012 - Conditions: Asthma; Bronchiolitis
Intervention:
Sponsors: iSonea; iSonea
Recruiting - verified March 2012 - Condition: Asthma
Intervention: Drug: Mometasone Furoate
Sponsors: Novartis; Novartis Pharmaceuticals
Not yet recruiting - verified May 2012 - Condition: Drug Safety
Interventions: Drug: MDT-637; Drug: Placebo
Sponsors: MicroDose Therapeutx, Inc; MicroDose Therapeutx, Inc
Recruiting - verified March 2012 - Condition: Asthma
Interventions: Drug: Borage and Echium Seed Oils; Drug: Corn oil pills
Sponsors: Brigham and Women's Hospital; Brigham and Women's Hospital; Wake Forest University
Not yet recruiting - verified March 2012 - Condition: Asthma
Interventions: Drug: ONO-6950; Drug: Placebo; Drug: Montelukast
Sponsors: Ono Pharma; Ono Pharma; Ono Pharmaceutical Co. Ltd
Not yet recruiting - verified April 2012 - Condition: Allergy
Interventions: Drug: QGE031; Drug: Placebo
Sponsors: Novartis; Novartis
Recruiting - verified May 2012 - Condition: Asthma
Interventions: Drug: Fluticasone propionate 100mcg; Drug: Placebo; Drug: Vilanterol
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Not yet recruiting - verified April 2012 - Condition: Asthma
Interventions: Drug: SB010; Drug: Placebo (phosphate-buffered saline)
Sponsors: Sterna Biologicals GmbH & Co. KG; Sterna Biologicals GmbH & Co. KG
Recruiting - verified April 2012 - Small Airways Disease in Asymptomatic and Symptomatic Subjects With Airway Hyperresponsiveness (AHR)Conditions: Asthma; Airway Hyperresponsiveness
Intervention:
Sponsors: University Medical Centre Groningen; University Medical Centre Groningen
Not yet recruiting - verified March 2012 - Condition: Asthma
Interventions: Drug: QAW039; Drug: Placebo
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified March 2012 - Condition: Asthma
Interventions: Drug: lebrikizumab; Drug: lebrikizumab; Drug: lebrikizumab; Drug: placebo
Sponsors: Genentech; Genentech
Recruiting - verified April 2012 - Condition: Asthma
Interventions: Drug: lebrikizumab; Drug: lebrikizumab; Drug: lebrikizumab; Drug: placebo
Sponsors: Genentech; Genentech
Recruiting - verified April 2012 - Conditions: Asthma; Chronic Obstructive Pulmonary Disease; Obstructive Sleep Apnea
Intervention: Drug: Inhaled Fluticasone Propionate
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Not yet recruiting - verified March 2012 - Condition: Asthma
Intervention: Other: Environmental Intervention
Sponsors: Columbia University; Columbia University; Agency for Healthcare Research and Quality (AHRQ)
Recruiting - verified May 2012 - Condition: Asthma
Interventions: Drug: Propranolol; Drug: Placebo; Drug: Qvar 50; Drug: Qvar 100
Sponsors: University of Dundee; University of Dundee; Chief Scientist Office of the Scottish Government
Not yet recruiting - verified February 2012 - Condition: Asthma
Interventions: Drug: SERETIDE Rotacaps; Drug: SERETIDE Diskus
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Recruiting - verified March 2012 - Condition: Bronchial Asthma With eNO-levels Greater Than 30 ppB
Intervention:
Sponsors: Johann Wolfgang Goethe University Hospitals; Johann Wolfgang Goethe University Hospitals
Recruiting - verified April 2012 - Conditions: Asthma; Allergic Rhinitis
Interventions: Drug: Alvesco/Omnaris, QVAR/Beconase, Placebo/Placebo; Drug: Alvesco/Omnaris, Placebo/Placebo, QVAR/Beconase; Drug: QVAR/Beconase, Alvesco/Omnaris, Placebo/Placebo; Drug: QVAR/Beconase, Placebo/Placebo, Alvesco/Omnaris; Drug: Placebo/Placebo, Alvesco/Omnaris, QVAR/Beconase; Drug: Placebo/Placebo, QVAR/Beconase, Alvesco/Omnaris
Sponsors: West Penn Allegheny Health System; West Penn Allegheny Health System
Not yet recruiting - verified March 2012 - Conditions: Asthma; Atopy
Interventions: Biological: Standardized Cat Allergen Extract and Standardized Dust Mite Allergen; Radiation: CT imaging, functional PET imaging; Drug: Nebulized methacholine inhalation
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; National Heart, Lung, and Blood Institute (NHLBI)
Not yet recruiting - verified March 2012 - Condition: Asthma
Interventions: Drug: ONO-6950; Drug: ONO-6950; Drug: Montelukast; Drug: Placebo
Sponsors: Ono Pharma; Ono Pharma; Ono Pharmaceutical Co. Ltd
Recruiting - verified March 2012 - Conditions: Asthma; Allergic Asthma; Non-allergic Asthma
Intervention: Biological: Allergen
Sponsors: The Cleveland Clinic; The Cleveland Clinic
Recruiting - verified February 2012 - Conditions: Bronchoconstriction; Asthma
Intervention: Device: The AlphaCore Device
Sponsors: ElectroCore LLC; ElectroCore LLC
Recruiting - verified February 2012 - Conditions: Asthma; Atopy
Interventions: Drug: fluticasone; Drug: Placebo
Sponsors: Milton S. Hershey Medical Center; dave mauger; National Heart, Lung, and Blood Institute (NHLBI)
Not yet recruiting - verified February 2012 - Condition: Asthma
Intervention: Drug: inhaled steroid
Sponsors: Belfast Health and Social Care Trust; Liam Heaney; Northern Ireland Chest Heart & Stroke
Recruiting - verified February 2012 - Condition: Asthma
Intervention:
Sponsors: Ottawa Hospital Research Institute; Ottawa Hospital Research Institute
Recruiting - verified May 2012 - Conditions: Allergic Asthma; Allergic Dermatitis; Allegic Rhinitis
Interventions: Drug: Omalizumab; Drug: Placebo; Drug: MEDI4212
Sponsors: MedImmune LLC; MedImmune LLC
Recruiting - verified May 2012 - Condition: Retinal Diseases
Interventions: Drug: GW824575; Drug: GW824575 matched-placebo
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Recruiting - verified March 2012 - Condition: Status Asthmaticus
Interventions: Drug: budesonide, albuterol, IB; Drug: Normal saline, albuterol, ipratropium bromide
Sponsors: King Saud University; King Saud University; King Fahad Medical City
Recruiting - verified February 2012 - Condition: Asthma
Interventions: Drug: HCP0910; Drug: Seretide Diskus
Sponsors: Hanmi Pharmaceutical Company Limited; Hanmi Pharmaceutical Company Limited
Recruiting - verified March 2012 - Conditions: Asthma; Viral Infection
Interventions: Drug: Mepolizumab; Drug: Placebo
Sponsors: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA); Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA); The Netherlands Asthma Foundation; GlaxoSmithKline
Recruiting - verified February 2012 - Condition: Asthma
Interventions: Drug: Magnesium Sulfate; Drug: Placebo
Sponsors: University of Louisville; University of Louisville
Recruiting - verified January 2012 - Condition: Asthma
Intervention: Behavioral: Home Based Asthma Education
Sponsors: Johns Hopkins University; Johns Hopkins University
Recruiting - verified January 2012 - Condition: Asthma
Interventions: Drug: Fluticasone, Budesonide, Beclomethasone; Drug: Fluticasone, Beclomethasone, Budesonide; Drug: Budesonide, Fluticasone, Beclomethasone; Drug: Budesonide, Beclomethasone, Fluticasone; Drug: Beclomethasone, Fluticasone, Budesonide; Drug: Beclomethasone, Budesonide, Fluticasone
Sponsors: West Penn Allegheny Health System; West Penn Allegheny Health System
Recruiting - verified February 2012 - Conditions: Asthma; Education
Intervention: Other: Asthma Transition Program
Sponsors: University of Calgary; University of Calgary
Recruiting - verified January 2012 - Condition: Asthma
Intervention: Other: Mobile-based Asthma Action Plan
Sponsors: Arkansas Children's Hospital Research Institute; Arkansas Children's Hospital Research Institute; University of Arkansas
Not yet recruiting - verified May 2012 - Condition: Asthma
Intervention:
Sponsors: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau; Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau; Sociedad Española de Neumología y Cirugía Torácica
Recruiting - verified January 2012 - Condition: Asthma
Intervention: Drug: Fluticasone Propionate
Sponsors: Dey; Dey
Not yet recruiting - verified January 2012 - Condition: Asthma
Intervention: Drug: Fluticasone Propionate (FP)
Sponsors: Dey; Dey
Not yet recruiting - verified January 2012 - Condition: Asthma
Interventions: Drug: RNS60; Drug: Normal Saline; Drug: Budesonide
Sponsors: Revalesio Corporation; Revalesio Corporation
Not yet recruiting - verified January 2012 - Condition: Asthma
Intervention: Drug: Nebulized magnesium sulfate
Sponsors: University of Texas Southwestern Medical Center; University of Texas Southwestern Medical Center
Recruiting - verified September 2011 - Conditions: Allergic Rhinitis; Asthma; Allergy
Interventions: Drug: Broccoli Sprouts; Drug: Placebo
Sponsors: Johns Hopkins University; Johns Hopkins University; National Institute of Environmental Health Sciences (NIEHS)
Not yet recruiting - verified January 2012 - Condition: Asthma
Intervention:
Sponsors: University of California, San Francisco; University of California, San Francisco
Recruiting - verified January 2012 - Conditions: Asthma; Exercise-Induced Bronchoconstriction
Interventions: Dietary Supplement: Lyprinol; Dietary Supplement: Placebo (Olive Oil)
Sponsors: Indiana University; Indiana University; Pharmalink
Recruiting - verified December 2011 - Condition: Eosinophilic Asthma
Interventions: Drug: Reslizumab; Drug: Matching Placebo
Sponsors: Teva Pharmaceutical Industries; Cephalon
Recruiting - verified May 2012 - Condition: Asthma
Intervention: Other: Exercise
Sponsors: Dasman Diabetes Institute; Dasman Diabetes Institute
Recruiting - verified December 2011 - Condition: Asthma
Interventions: Drug: Mometasone Furoate (MF) Metered Dose Inhaler (MDI), 25 mcg; Drug: Mometasone Furoate (MF) Metered Dose Inhaler (MDI), 50 mcg; Drug: Mometasone Furoate (MF) Metered Dose Inhaler (MDI), 100 mcg; Drug: Mometasone Furoate (MF) Dry Powder Inhaler (DPI), 100 mcg; Drug: Placebo Metered Dose Inhaler (MDI); Drug: Placebo Dry Powder Inhaler (DPI)
Sponsors: Schering-Plough; Schering-Plough
Recruiting - verified April 2012 - Condition: Asthma
Interventions: Drug: AIM-102, D-cyclohexylalanine-D-glutamic-glycine tripeptide; Drug: Buffered Saline
Sponsors: AIM Therapeutics Inc.; AIM Therapeutics Inc.
Not yet recruiting - verified December 2011 - Condition: Asthma
Intervention:
Sponsors: Capital Institute of Pediatrics, China; Capital Institute of Pediatrics, China; Merck
Recruiting - verified December 2011 - Condition: Asthma
Interventions: Drug: GW685698/GW642444; Drug: Placebo
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Recruiting - verified April 2012 - Condition: Asthma
Interventions: Drug: GW685698/GW642444; Drug: CCI18781
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Recruiting - verified May 2012 - Condition: Asthma
Interventions: Drug: AMG 761; Drug: Placebo
Sponsors: Amgen; Amgen
Recruiting - verified January 2012 - Condition: Asthma
Interventions: Device: NIPPV (PALMtop PTV); Device: Volumetric CO2 (NM3); Device: USCOM
Sponsors: Vanderbilt University; Vanderbilt University
Not yet recruiting - verified April 2012 - Condition: Asthma
Interventions: Drug: Flutiform; Drug: Seretide; Drug: Flixotide
Sponsors: Mundipharma Research Limited; Mundipharma Research Limited
Not yet recruiting - verified February 2012 - Conditions: Atopy; Atopic Dermatitis; Asthma; Allergic Rhinitis; Food Allergy
Intervention:
Sponsors: Meir Medical Center; Meir Medical Center
Recruiting - verified April 2012 - Condition: Asthma
Interventions: Drug: Placebo; Drug: Flovent Diskus; Drug: Fluticasone propionate DPI Dose 1; Drug: Fluticasone propionate DPI Dose 2; Drug: Fluticasone propionate DPI Dose 3; Drug: Fluticasone propionate DPI Dose 4
Sponsors: Teva Pharmaceutical Industries; Teva Pharmaceutical Industries; PPD
Recruiting - verified May 2012 - Condition: Asthma
Interventions: Drug: QBX258; Drug: Placebo
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified May 2012 - Condition: Asthma
Interventions: Drug: AIN457 (secukinumab); Drug: Placebo
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified May 2012 - Condition: Asthma
Interventions: Drug: ADVAIR 100/50mcg; Drug: ADVAIR 250/50mcg; Drug: ADVAIR 500/50mcg; Drug: FLOVENT 100mcg; Drug: FLOVENT 250mcg; Drug: FLOVENT 500mcg
Sponsors: GlaxoSmithKline; GlaxoSmithKline; Parexel
Recruiting - verified May 2012 - Condition: Asthma
Interventions: Drug: Placebo; Drug: Primatene Mist; Drug: Epinephrine inhalation aerosol, HFA; Drug: epinephrine inhalation aerosol
Sponsors: Amphastar Pharmaceuticals, Inc.; Amphastar Pharmaceuticals, Inc.
Recruiting - verified November 2011 - Condition: Asthma
Interventions: Drug: Indacaterol Maleate (high dose; Form 1) and Placebo (Form 2); Drug: Placebo (Form 1) and Indacaterol Maleate (high dose; Form 2); Drug: Placebo (Form 1) and Indacaterol Maleate (low dose; Form 2); Drug: Placebo (Form 1) and Placebo (Form 2)
Sponsors: Novartis; Novartis
Recruiting - verified December 2011 - Conditions: Childhood Asthma; Oxidative Stress
Intervention:
Sponsors: Stony Brook University; Stony Brook University
Recruiting - verified November 2011 - Condition: Asthma
Intervention: Drug: VR506
Sponsors: Vectura Limited; Vectura Limited
Recruiting - verified November 2011 - Condition: Asthma
Interventions: Drug: Mometasone Furoate/Formoterol MDI 100/5 mcg; Drug: Mometasone Furoate/Formoterol MDI 200/5 mcg; Drug: Mometasone Furoate MDI 100 mcg; Drug: Mometasone Furoate MDI 200 mcg; Drug: Albuterol 90 mcg /salbutamol 100 mcg HFA MDI; Drug: Prednisone/prednisolone
Sponsors: Schering-Plough; Schering-Plough
Recruiting - verified April 2012 - Condition: Asthma
Interventions: Drug: salbutamol; Drug: Salbutamol - dose2; Drug: Salbutamol -dose3; Drug: salbutamol -dose4
Sponsors: Assistance Publique - Hôpitaux de Paris; Assistance Publique - Hôpitaux de Paris
Not yet recruiting - verified July 2011 - Condition: Asthma in Children
Interventions: Drug: free comb. beclomethasone DPI and formoterol DPI; Drug: CHF 1535 50/6 NEXT DPI
Sponsors: Chiesi Farmaceutici S.p.A.; Chiesi Farmaceutici S.p.A.
Not yet recruiting - verified November 2011 - Condition: Asthma
Interventions: Drug: ADVAIR 100/50mcg; Drug: ADVAIR 250/50mcg; Drug: FLOVENT 100mcg; Drug: FLOVENT 250mcg
Sponsors: GlaxoSmithKline; GlaxoSmithKline; Parexel
Recruiting - verified May 2012 - Condition: Asthma
Intervention: Other: Self management asthma plan indorsment.
Sponsors: The University Clinic of Pulmonary and Allergic Diseases Golnik; The University Clinic of Pulmonary and Allergic Diseases Golnik; University of Primorska
Recruiting - verified October 2011 - Condition: Asthma
Intervention: Drug: Budesonide
Sponsors: University of California, San Francisco; University of California, San Francisco; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified November 2011 - Condition: Asthma
Intervention: Drug: Epinephrine Inhalation Aerosol
Sponsors: Amphastar Pharmaceuticals, Inc.; Amphastar Pharmaceuticals, Inc.
Recruiting - verified October 2011 - Condition: Bronchial Asthma
Intervention: Drug: Ciclesonide
Sponsors: Nycomed; Nycomed
Recruiting - verified May 2012 - Condition: Asthma
Intervention: Device: Beclomethasone/formoterol pMDI with or without Vortex spacer
Sponsors: Universidade Federal de Pernambuco; Universidade Federal de Pernambuco; Universidade Federal do Vale do São Francisco
Recruiting - verified October 2011 - Condition: Asthma
Interventions: Drug: CHF 1535; Drug: Beclomethasone (BDP); Drug: Beclomethasone (BDP) + Formoterol Fumarate (FF)
Sponsors: Chiesi Farmaceutici S.p.A.; Chiesi Farmaceutici S.p.A.
Recruiting - verified December 2011 - Condition: Asthma
Intervention:
Sponsors: Sociedad Española de Neumología y Cirugía Torácica; Sociedad Española de Neumología y Cirugía Torácica; Merck
Recruiting - verified October 2011 - Condition: Asthma
Intervention: Other: Methacholine challenge testing
Sponsors: Johann Wolfgang Goethe University Hospitals; Johann Wolfgang Goethe University Hospitals
Recruiting - verified March 2012 - Condition: Asthma
Interventions: Drug: masitinib 6 mg/kg/day; Drug: placebo
Sponsors: AB Science; AB Science
Recruiting - verified October 2011 - Conditions: Asthma; Childhood Asthma
Intervention: Behavioral: education
Sponsors: University of Louisville; University of Louisville
Recruiting - verified October 2011 - Condition: Asthma
Intervention: Drug: Vitamin D
Sponsors: Georgia Health Sciences University; Georgia Health Sciences University
Recruiting - verified October 2011 - Conditions: Asthma; Psychosocial Stress
Interventions: Behavioral: Stress management program; Other: Peer viewed movies
Sponsors: Weill Medical College of Cornell University; Weill Medical College of Cornell University
Recruiting - verified September 2011 - Condition: Asthma
Intervention: Behavioral: Reinforced Asthma Education
Sponsors: University of Louisville; University of Louisville; Passport Health
Recruiting - verified October 2011 - Conditions: Sickle Cell Disease; Vitamin D Deficiency; Acute Chest Syndrome; Asthma; Respiratory Infections
Interventions: Drug: Vitamin D3; Drug: Vitamin D3
Sponsors: Columbia University; Columbia University
Recruiting - verified January 2012 - Condition: Asthma
Interventions: Drug: Symbicort pMDI; Drug: Symbicort pMDI; Drug: budesonide pMDI; Drug: budesonide pMDI
Sponsors: AstraZeneca; AstraZeneca
Recruiting - verified March 2012 - Condition: Asthma
Intervention: Behavioral: Educational program: consultation with paediatric pulmonologist
Sponsors: University Hospital, Clermont-Ferrand; University Hospital, Clermont-Ferrand
Not yet recruiting - verified November 2011 - Condition: Childhood Asthma
Interventions: Drug: CHF 1535 50/6µg; Drug: beclomethasone dipropionate 50µg + formoterol fumarate 6µg
Sponsors: Chiesi Farmaceutici S.p.A.; Chiesi Farmaceutici S.p.A.
Recruiting - verified October 2011 - Condition: Asthma
Interventions: Drug: Zithromax; Drug: Placebo
Sponsors: Imperial College London; Imperial College London; National Institute for Health Research, United Kingdom
Not yet recruiting - verified September 2011 - Condition: Asthma
Intervention:
Sponsors: National Taiwan University Hospital; National Taiwan University Hospital
Not yet recruiting - verified September 2011 - Condition: Asthma
Interventions: Other: Video game group; Other: Aerobic exercise; Other: Resistance
Sponsors: Hospital Sirio-Libanes; Hospital Sirio-Libanes; University of Nove de Julho
Recruiting - verified January 2012 - Condition: Asthma
Interventions: Drug: Fluticasone furoate 50mcg; Drug: Placebo
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Recruiting - verified April 2012 - Condition: Asthma
Interventions: Drug: Fluticasone furoate 50mcg; Drug: Fluticasone propionate 100mcg; Drug: Placebo
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Recruiting - verified March 2012 - Condition: Activity/Exercise Induced Bronchospasm
Interventions: Drug: Fluticasone Furoate/Vilanterol Inhalation Powder; Drug: Fluticasone Propionate Inhalation Powder
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Not yet recruiting - verified October 2011 - Condition: Asthma
Interventions: Drug: Revamilast; Drug: Revamilast; Drug: Revamilast; Drug: Placebo
Sponsors: Glenmark Pharmaceuticals Ltd. India; Glenmark Pharmaceuticals Ltd. India; Glenmark Pharmaceuticals SA
Recruiting - verified January 2012 - Condition: Asthma
Interventions: Drug: QAW039; Drug: Comparator leukotriene receptor antagonist (LRTA); Drug: Placebo
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified May 2012 - Condition: Asthma
Intervention: Procedure: Cockroach mitigation/extermination
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Environmental Health Sciences (NIEHS)
Not yet recruiting - verified November 2011 - Condition: Vitamin D Deficiency
Intervention:
Sponsors: Mahidol University; Mahidol University
Recruiting - verified September 2011 - Condition: Asthma
Intervention:
Sponsors: Handok Pharmaceuticals Co., Ltd.; Handok Pharmaceuticals Co., Ltd.
Recruiting - verified September 2011 - Condition: Asthma
Interventions: Drug: Fluticasone/Salmeterol Diskus; Drug: Fluticasone/Salmeterol Diskus; Drug: Fluticasone Diskus
Sponsors: Johns Hopkins University; Johns Hopkins University; American Lung Association; GlaxoSmithKline
Recruiting - verified May 2012 - Condition: Asthma
Interventions: Biological: Omalizumab; Drug: Fluticasone; Other: Placebo
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2012 - Condition: Acute Viral Bronchiolitis
Intervention:
Sponsors: University Hospital, Clermont-Ferrand; University Hospital, Clermont-Ferrand
Not yet recruiting - verified September 2011 - Conditions: Asthma; Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Behavioral: Teach-To-Goal; Behavioral: Brief Intervention
Sponsors: University of Chicago; University of Chicago
Recruiting - verified September 2011 - Condition: Asthma
Interventions: Drug: YHD001 dose level 1; Drug: YHD001 dose level 2; Drug: Singulair; Drug: Placebo
Sponsors: Yuhan Corporation; Yuhan Corporation
Recruiting - verified January 2012 - Condition: Atopic Asthma
Interventions: Procedure: Bone Marrow Aspiration; Procedure: Tonsil Biopsy
Sponsors: Hamilton Health Sciences Corporation; Hamilton Health Sciences Corporation; Genentech
Recruiting - verified April 2012 - Conditions: Respiratory Tract Infections; Asthma; Avitaminosis
Interventions: Drug: Vitamin D - Cholecalciferol 400 IU; Drug: Vitamin D3 - Cholecalciferol 2000 IU
Sponsors: The Hospital for Sick Children; The Hospital for Sick Children; Mount Sinai Hospital, Canada; St. Michael's Hospital, Toronto
Recruiting - verified September 2011 - Conditions: Premature Baby 26 to 32 Weeks; Bronchopulmonary Dysplasia
Intervention: Other: Prevention and follow-up of the patients pulmonary parameters
Sponsors: Assistance Publique - Hôpitaux de Paris; Assistance Publique - Hôpitaux de Paris
Not yet recruiting - verified August 2011 - Condition: Asthma
Interventions: Drug: KHK4563; Drug: KHK4563; Drug: KHK4563; Drug: Placebo
Sponsors: Kyowa Hakko Kirin Company, Limited; Kyowa Hakko Kirin Company, Limited
Recruiting - verified October 2011 - Conditions: Asthma; Bronchiolitis
Intervention:
Sponsors: KarmelSonix Ltd.; KarmelSonix Ltd.; Hadassah Medical Organization
Not yet recruiting - verified August 2011 - Condition: Asthma
Intervention: Other: Pictogram-based asthma action plan
Sponsors: New York University School of Medicine; New York University School of Medicine; Feinberg School of Medicine, Northwestern University
Recruiting - verified July 2011 - Condition: Asthma
Interventions: Drug: AMG 157 Matching Placebo; Drug: AMG 157
Sponsors: Amgen; Amgen
Not yet recruiting - verified January 2012 - Condition: Asthma
Intervention: Drug: Tralokinumab
Sponsors: MedImmune LLC; MedImmune LLC
Recruiting - verified January 2012 - Condition: Asthma
Interventions: Drug: 100 micrograms Fluticasone propionate; Drug: 500 micrograms Fluticasone propionate; Drug: lactose powder
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Recruiting - verified January 2012 - Condition: Status Asthmaticus
Interventions: Other: Noninvasive positive pressure ventilation; Other: standard of care
Sponsors: Southern Illinois University; Southern Illinois University
Recruiting - verified February 2012 - Condition: Asthma
Intervention:
Sponsors: Fiks, Iara Nely, M.D.; Fiks, Iara Nely, M.D.
Not yet recruiting - verified July 2011 - Conditions: Asthma; Allergic Asthma; Non-allergic Asthma
Interventions: Drug: levocetirizine; Other: placebo
Sponsors: Children's Mercy Hospital Kansas City; Children's Mercy Hospital Kansas City
Recruiting - verified July 2011 - Condition: Asthma
Intervention: Drug: Vitamin D
Sponsors: Hamad Medical Corporation; Hamad Medical Corporation
Recruiting - verified March 2012 - Condition: Asthma
Intervention: Drug: Flovent Diskus, Advair Diskus, Ventolin HFA, cetirizine, Flonase Nasal Spray, Singulair
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified August 2011 - Condition: Bronchial Asthma
Interventions: Drug: Keratinocyte Growth factor; Drug: Saline placebo
Sponsors: Southampton University Hospitals NHS Trust; Southampton University Hospitals NHS Trust
Recruiting - verified June 2010 - Condition: Asthma
Intervention: Drug: ASM8
Sponsors: Pharmaxis; Pharmaxis
Not yet recruiting - verified June 2011 - Conditions: Autoimmune Diseases; Asthma
Interventions: Other: Regimen; Other: Standard regimen
Sponsors: Assistance Publique - Hôpitaux de Paris; Assistance Publique - Hôpitaux de Paris
Recruiting - verified September 2011 - Condition: Asthma
Interventions: Behavioral: Motivational Interviewing; Behavioral: Control
Sponsors: Hopital du Sacre-Coeur de Montreal; Hopital du Sacre-Coeur de Montreal; Jewish General Hospital
Recruiting - verified October 2011 - Condition: Asthma
Interventions: Drug: Tiotropium bromide; Drug: Tiotropium bromide; Drug: Tiotropium bromide; Drug: Tiotropium bromide
Sponsors: Boehringer Ingelheim Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals; Pfizer
Recruiting - verified May 2012 - Conditions: Asthma; Chronic Obstructive Pulmonary Disease
Intervention:
Sponsors: AstraZeneca; AstraZeneca
Not yet recruiting - verified June 2011 - Condition: OSA
Interventions: Procedure: CPAP group; Procedure: non CPAP group
Sponsors: Chinese University of Hong Kong; Chinese University of Hong Kong
Recruiting - verified January 2011 - Condition: Asthma
Intervention:
Sponsors: AstraZeneca; AstraZeneca
Recruiting - verified March 2012 - Condition: Wheezy Bronchitis
Interventions: Drug: Magnesium Sulfate; Drug: Placebo
Sponsors: University of Oulu; University of Oulu
Recruiting - verified June 2011 - Conditions: Asthma; Obstructive Sleep Apnea Syndrome
Intervention: Device: CPAP
Sponsors: Cimera; Cimera
Not yet recruiting - verified June 2011 - Condition: Asthma
Interventions: Biological: Mepolizumab 250 mg subcutaneous (SC); Biological: Mepolizumab 125 mg subcutaneous (SC); Biological: Mepolizumab 12.5 mg subcutaneous (SC)
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Recruiting - verified October 2011 - Condition: Asthma
Intervention:
Sponsors: University Medical Centre Groningen; University Medical Centre Groningen; Chiesi Farmaceutici S.p.A.
Recruiting - verified September 2011 - Conditions: Primary Prevention; Diabetes Mellitus; Asthma; Cardiovascular Diseases; Heart Failure; Mental Health; Osteoporosis
Intervention:
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs; Regenstrief Institute, IU Center for Aging Research
Not yet recruiting - verified March 2012 - Conditions: Proctitis; Proctosigmoiditis
Intervention: Drug: Budesonide Foam
Sponsors: Salix Pharmaceuticals; Salix Pharmaceuticals
Recruiting - verified July 2011 - Condition: Severe Asthma
Intervention: Device: Alair System
Sponsors: Asthmatx, Inc.; Asthmatx, Inc.; Boston Scientific Corporation
Recruiting - verified March 2012 - Condition: Allergic Asthma
Intervention: Drug: Omalizumab
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified May 2012 - Conditions: Asthma; Children
Interventions: Drug: Albuterol - Experimental; Drug: Albuterol - Control
Sponsors: University of Sao Paulo; University of Sao Paulo; Fundação de Amparo à Pesquisa do Estado de São Paulo
Recruiting - verified January 2012 - Conditions: Asthma; Obesity; Inflammation
Interventions: Drug: Montelukast; Drug: Placebo; Drug: Montelukast; Drug: Placebo
Sponsors: North Shore Long Island Jewish Health System; North Shore Long Island Jewish Health System; Thrasher Research Fund; Merck
Recruiting - verified January 2012 - Condition: Asthma
Interventions: Biological: SAR231893 (REGN668); Drug: placebo
Sponsors: Sanofi-Aventis; Sanofi-Aventis; Regeneron Pharmaceuticals
Recruiting - verified April 2012 - Condition: Asthma
Intervention: Drug: PL-3994
Sponsors: Palatin Technologies; Palatin Technologies
Not yet recruiting - verified May 2012 - Condition: Asthma
Intervention:
Sponsors: American Academy of Family Physicians; American Academy of Family Physicians; American Academy of Allergy, Asthma, and Immunology
Recruiting - verified January 2012 - Condition: Eosinophilic Asthma
Interventions: Drug: Reslizumab; Drug: Placebo
Sponsors: Teva Pharmaceutical Industries; Cephalon
Recruiting - verified May 2012 - Condition: Eosinophilic Asthma
Interventions: Drug: Reslizumab; Drug: Placebo
Sponsors: Teva Pharmaceutical Industries; Cephalon
Recruiting - verified May 2012 - Condition: Asthma
Interventions: Drug: tiotropium low dose; Drug: tiotropium high dose; Drug: placebo
Sponsors: Boehringer Ingelheim Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals; Pfizer
Recruiting - verified May 2012 - Conditions: Nasal Polyp; Smoking; Rhinosinusitis; Allergic Rhinitis; Deviated Nasal Septum; ASA Intolerant Asthma
Intervention:
Sponsors: Karnataka Institute of Medical Sciences; Karnataka Institute of Medical Sciences; Ministry of Science and Technology, India; Applied Genetics; Lab Discoveries Ltd.
Recruiting - verified April 2012 - Condition: Asthma
Intervention: Drug: Budesonide dry powder inhaler
Sponsors: NovaMed Pharmaceuticals Inc.; NovaMed Pharmaceuticals Inc.
Recruiting - verified April 2011 - Condition: Eosinophilic Asthma
Interventions: Drug: Reslizumab; Drug: Reslizumab; Drug: Placebo
Sponsors: Teva Pharmaceutical Industries; Cephalon
Recruiting - verified May 2012 - Condition: Asthma
Interventions: Drug: Tiotropium; Drug: Salmeterol; Drug: Formoterol
Sponsors: Brigham and Women's Hospital; Brigham and Women's Hospital; Olmsted Medical Center; American Academy of Family Physicians National Research Network; Harvard Clinical Research Institute
Recruiting - verified March 2012 - Condition: Asthma
Interventions: Drug: tiotropium Respimat low dose; Drug: tiotropium Respimat high dose; Drug: placebo Respimat
Sponsors: Boehringer Ingelheim Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals; Pfizer
Recruiting - verified May 2012 - Condition: Asthma
Interventions: Behavioral: PACE; Behavioral: PACE Plus
Sponsors: University of Michigan; University of Michigan
Recruiting - verified July 2011 - Conditions: Asthma; Mouse Allergy; Mouse Allergen Exposure
Interventions: Other: Integrated Pest Management; Other: Education
Sponsors: Johns Hopkins University; Johns Hopkins University; Children's Hospital Boston; Columbia University
Recruiting - verified January 2012 - Condition: Asthma
Intervention: Other: Text Message Reminders
Sponsors: Children's Hospital Medical Center, Cincinnati; Children's Hospital Medical Center, Cincinnati; CMSText
Recruiting - verified June 2011 - Condition: Asthma
Interventions: Drug: Vitamin D3; Drug: Ciclesonide
Sponsors: Milton S. Hershey Medical Center; Milton S. Hershey Medical Center; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified March 2012 - Conditions: Asthma; Reactive Airway Disease
Interventions: Drug: Dexamethasone; Drug: Prednisone
Sponsors: Alameda County Medical Center; Alameda County Medical Center
Recruiting - verified January 2012 - Condition: Asthma
Interventions: Drug: Fixed dose combination salmeterol / fluticasone; Drug: Fixed-dose combination beclometasone dipropionate / formoterol
Sponsors: Research in Real-Life Ltd; Research in Real-Life Ltd; Chiesi Farmaceutici S.p.A.
Recruiting - verified June 2011 - Conditions: Atopic Dermatitis; Vitamin D Deficiency; Asthma
Intervention:
Sponsors: Medical College of Wisconsin; Medical College of Wisconsin; Children's Hospital and Health System Foundation, Wisconsin
Recruiting - verified July 2011 - Condition: Childhood Asthma With Acute Exacerbation
Intervention: Drug: Azithromycin
Sponsors: Copenhagen Studies on Asthma in Childhood; Copenhagen Studies on Asthma in Childhood
Recruiting - verified February 2012 - Conditions: Asthma; Health
Intervention: Other: All patients
Sponsors: Centocor, Inc.; Centocor, Inc.
Recruiting - verified May 2012 - Condition: Persistent Asthma Patient
Intervention:
Sponsors: Ajou University School of Medicine; Ajou University School of Medicine; Yonsei University; Inha University Hospital; Dong-A University
Recruiting - verified February 2012 - Condition: Asthma
Interventions: Drug: budesonide/formoterol or fluticasone/salmeterol; Drug: budesonide/formoterol or fluticasone/salmeterol
Sponsors: Gelb, Arthur F., M.D.; Gelb, Arthur F., M.D.
Recruiting - verified August 2011 - Conditions: Depression; Asthma
Interventions: Drug: Escitalopram; Drug: Placebo
Sponsors: University of Texas Southwestern Medical Center; University of Texas Southwestern Medical Center; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified March 2012 - Conditions: Respiratory Syncytial Virus; Asthma
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Environmental Health Sciences (NIEHS)
Recruiting - verified August 2011 - Condition: Asthma
Intervention: Drug: Beclomethasone
Sponsors: Universitaire Ziekenhuizen Leuven; Universitaire Ziekenhuizen Leuven
Recruiting - verified October 2011 - Conditions: Asthma Patients; Healthy Subjects
Intervention:
Sponsors: Universitaire Ziekenhuizen Leuven; Universitaire Ziekenhuizen Leuven
Recruiting - verified October 2011 - Condition: Asthmatic Patients
Interventions: Drug: Montelukast; Drug: long acting beta2 mimetic
Sponsors: Universitaire Ziekenhuizen Leuven; Universitaire Ziekenhuizen Leuven
Recruiting - verified October 2011 - Condition: Asthmatic Patients
Intervention: Drug: azithromycin
Sponsors: Universitaire Ziekenhuizen Leuven; Universitaire Ziekenhuizen Leuven
Recruiting - verified October 2011 - Conditions: Asthma; Allergic Rhinitis
Interventions: Dietary Supplement: Lipoic acid; Dietary Supplement: Placebo capsule
Sponsors: Centro Universitario de Ciencias de la Salud, Mexico; Centro Universitario de Ciencias de la Salud, Mexico; Hospital Civil Juan I. Menchaca; National Council of Science and Technology, Mexico
Recruiting - verified February 2011 - Conditions: Collection of Clinical Data That Will be Used in This Study and Will Form a Data Bank for Asthma in Saudi Arabia; Identify Known and NOVEL Genetic Risk Factors Contributing to Asthma Susceptibility; Study the Mechanistic Roles of the Genetic Variants Within Major Asthma Susceptibility Genes
Intervention:
Sponsors: King Saud University; King Saud University
Recruiting - verified October 2011 - Condition: Persistent Allergic Asthma
Interventions: Drug: Omalizumab; Drug: Placebo
Sponsors: Novartis; Novartis Pharmaceuticals; Genentech
Recruiting - verified January 2012 - Condition: Asthma Exacerbation
Intervention: Drug: Budesonide turbuhaler, Budesonide+Formoterol turbuhaler
Sponsors: Meir Medical Center; Meir Medical Center
Recruiting - verified March 2012 - Condition: Asthma
Interventions: Behavioral: Education and Peer Support; Behavioral: Asthma Education
Sponsors: Rush University Medical Center; Rush University Medical Center; National Institutes of Health (NIH); GlaxoSmithKline
Recruiting - verified December 2011 - Conditions: Asthma; Quality of Life; Children; Health Disparities; Telemedicine Education
Interventions: Other: Asthma Education Sessions; Other: Asthma Health Assessment via Telemonitoring; Other: Provider Treatment Prompt; Other: School Absenteeism; Other: Prescription Filling Profile
Sponsors: Arkansas Children's Hospital Research Institute; Arkansas Children's Hospital Research Institute; National Institutes of Health (NIH); University of Arkansas
Recruiting - verified January 2012 - Condition: Asthma
Interventions: Drug: Citalopram; Drug: Placebo
Sponsors: Belfast Health and Social Care Trust; Liam Heaney; Asthma UK
Recruiting - verified February 2012 - Condition: Asthma
Interventions: Drug: Ciclesonide; Drug: Placebo
Sponsors: University of Nottingham; University of Nottingham; Nottingham University Hospitals NHS Trust; University Hospitals, Leicester
Recruiting - verified January 2012 - Conditions: Persistent Asthma; Elderly
Interventions: Drug: Combination of low ICS and montelukast; Drug: Monotherapy of medium dose ICS
Sponsors: Ajou University School of Medicine; Ajou University School of Medicine; Hallym University Medical Center; Yonsei University; Korea University Guro Hospital; Sanofi Pasteur MSD
Recruiting - verified February 2012 - Conditions: Asthma; Atherosclerosis; Metabolic Syndrome; Insulin Resistance; Cancer
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Environmental Health Sciences (NIEHS)
Recruiting - verified March 2012 - Condition: Asthma
Interventions: Drug: budesonide; Drug: placebo
Sponsors: AstraZeneca; AstraZeneca
Recruiting - verified May 2012 - Condition: Asthma
Intervention: Drug: Pioglitazone
Sponsors: University of Nottingham; University of Nottingham
Recruiting - verified November 2011 - Condition: Asthma
Intervention: Behavioral: Telephone counseling intervention
Sponsors: University of Michigan; University of Michigan
Recruiting - verified July 2011 - Condition: Asthma
Interventions: Drug: fluticasone propionate and salmeterol; Drug: budesonide and formoterol
Sponsors: National Jewish Health; National Jewish Health
Recruiting - verified July 2011 - Conditions: Asthma; Rhinitis; Sinusitis
Interventions: Drug: Mometasone Furoate monohydrate; Other: Placebo
Sponsors: American Lung Association Asthma Clinical Research Centers; American Lung Association Asthma Clinical Research Centers; National Institutes of Health (NIH); National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified June 2011 - Conditions: Asthma; Allergic Rhinitis
Intervention:
Sponsors: University of British Columbia; University of British Columbia; Allergy, Genes and Environment Network (AllerGen); Networks of Centres of Excellence (NCE)
Recruiting - verified November 2011 - Condition: Asthma
Interventions: Dietary Supplement: Magnesium supplement (magnesium hydroxide/ -oxide); Dietary Supplement: Placebo
Sponsors: University of Aarhus; University of Aarhus; Gunnar Kjems APS; GCP-unit at Aarhus University Hospital, Aarhus, Denmark; Dept. of Clinical Biochemistry, Aarhus University Hospital, Aarhus, Denmark
Recruiting - verified March 2012 - Condition: Asthma
Interventions: Other: PELICAN Primary Care; Other: PELICAN Secondary Care
Sponsors: Radboud University; Radboud University
Recruiting - verified February 2012 - Condition: Asthma
Intervention: Behavioral: Multifaceted Prompting Intervention MPI
Sponsors: University of Rochester; University of Rochester; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified August 2011 - Conditions: Rhinitis, Allergic; Asthma, Allergic
Interventions: Biological: Classification as "asthmatic" or "rhinitis only" via proteomic analysis; Biological: Classification as "asthmatic" or "rhinitis only" according to a metacholine test
Sponsors: Centre Hospitalier Universitaire de Nīmes; Centre Hospitalier Universitaire de Nīmes
Recruiting - verified February 2012 - Conditions: Chronic Obstructive Pulmonary Disease (COPD); Asthma
Interventions: Other: Pulmonary disease management; Other: Usual care
Sponsors: Sheba Medical Center; Sheba Medical Center; Maccabi Health Services
Recruiting - verified June 2011 - Condition: Asthma
Interventions: Drug: Imatinib mesylate; Drug: Placebo
Sponsors: Brigham and Women's Hospital; Brigham and Women's Hospital; Harvard Clinical Research Institute; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified March 2012 - Condition: Asthma
Intervention: Drug: 10 mg tablet of montelukast (Singulair)
Sponsors: Nemours Children's Clinic; Nemours Children's Clinic; Merck
Recruiting - verified November 2011 - Condition: Acute Asthma
Interventions: Behavioral: Opinion Leader letter; Behavioral: Involvement of a care manager; Behavioral: Usual care
Sponsors: University of Alberta; University of Alberta
Not yet recruiting - verified April 2012 - Condition: Asthma
Intervention:
Sponsors: University of California, San Francisco; University of California, San Francisco; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified September 2011 - Trial on the Effect of Budesonide/Formoterol and Inhaled Budesonide Alone on Exercise-Induced AsthmaCondition: Exercise Induced Asthma
Interventions: Drug: Budesonide/Formoterol; Drug: Budesonide
Sponsors: Children's Hospital Boston; Children's Hospital Boston; Brigham and Women's Hospital
Recruiting - verified June 2011 - Conditions: Asthma; Cough Variant Asthma
Interventions: Drug: high-dose methacholine challenge test; Other: mannitol challenge test
Sponsors: Queen's University; Queen's University; The Ontario Thoracic Society of the Ontario Lung Association; Queen's University (William M Spear / Start Memorial Fund)
Recruiting - verified April 2012 - Condition: Bronchiolitis
Interventions: Drug: Dexamethasone; Drug: Placebo
Sponsors: Hamad Medical Corporation; Hamad Medical Corporation
Recruiting - verified February 2012 - Conditions: Wheezing; Asthma; Allergy
Interventions: Biological: Allergen extracts (subcutaneous injections); Other: Standard of care
Sponsors: Albert Einstein College of Medicine of Yeshiva University; Albert Einstein College of Medicine of Yeshiva University; Jacobi Medical Center
Recruiting - verified June 2011 - Conditions: Asthma; Obesity
Interventions: Dietary Supplement: omega-3 polyunsaturated fatty acids; Dietary Supplement: placebo
Sponsors: Nemours Children's Clinic; Nemours Children's Clinic; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified October 2010 - Conditions: Asthma; Obstructive Sleep Apnea
Interventions: Other: FDA-Approved Treatment; Other: No intervention for Control Group
Sponsors: University of Wisconsin, Madison; University of Wisconsin, Madison
Recruiting - verified September 2011 - Condition: Asthma
Intervention: Biological: Segmental Allergen Challenge
Sponsors: University of Wisconsin, Madison; University of Wisconsin, Madison; National Institutes of Health (NIH)
Recruiting - verified September 2011 - Condition: Asthma
Intervention: Behavioral: Wee Wheezers
Sponsors: Montefiore Medical Center; Montefiore Medical Center; American Lung Association
Recruiting - verified July 2011 - Conditions: Proctitis; Proctosigmoiditis
Interventions: Drug: Budesonide; Drug: Placebo
Sponsors: Salix Pharmaceuticals; Salix Pharmaceuticals
Recruiting - verified July 2011 - Conditions: Proctitis; Proctosigmoiditis
Interventions: Drug: Budesonide; Drug: Placebo
Sponsors: Salix Pharmaceuticals; Salix Pharmaceuticals
Recruiting - verified July 2011 - Condition: Asthma
Intervention: Drug: Fluticasone propionate / Formoterol fumarate
Sponsors: Mundipharma Research Limited; Mundipharma Research Limited
Recruiting - verified February 2012 - Conditions: Asthma; COPD
Intervention: Drug: broccoli sprout extract
Sponsors: Johns Hopkins University; Johns Hopkins University
Recruiting - verified March 2012 - Conditions: Severe, Refractory Asthma; Airway Inflammation; Airflow Obstruction
Intervention: Drug: Pioglitazone
Sponsors: National Institutes of Health Clinical Center (CC); National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified July 2011 - Conditions: Asthma; Cystic Fibrosis; Chronic Lung Disease; Pneumonia
Intervention:
Sponsors: Maastricht University Medical Center; Maastricht University Medical Center
Recruiting - verified July 2011 - Condition: ASTHMA
Interventions: Behavioral: Capnometry Assisted Respiration Training; Behavioral: Breathing Awareness
Sponsors: Southern Methodist University; Southern Methodist University; National Heart, Lung, and Blood Institute (NHLBI); Baylor Health Care System
Recruiting - verified September 2009 - Conditions: Asthma; Rhinitis
Intervention: Drug: Mometasone furoate and desloratadine
Sponsors: Laval University; Laval University
Recruiting - verified February 2012 - Condition: Asthma
Interventions: Behavioral: Aerobic exercise; Behavioral: Usual care
Sponsors: Hopital du Sacre-Coeur de Montreal; Hopital du Sacre-Coeur de Montreal; McGill University Health Center
Recruiting - verified October 2011 - Conditions: Hypertension; Asthma
Interventions: Other: PPCM Asthma; Other: 24 Month PPCM BP; Other: 9 Month PPCM HTN
Sponsors: University of Iowa; University of Iowa
Recruiting - verified June 2010 - Conditions: Dermatophagoides Farinae Allergy; Asthma; Healthy
Intervention: Other: dust mite inhalation
Sponsors: University of North Carolina, Chapel Hill; University of North Carolina, Chapel Hill; National Institutes of Health (NIH)
Not yet recruiting - verified November 2011 - Condition: Asthma
Interventions: Drug: Methoxyverapamil (gallopamil); Drug: Placebo.
Sponsors: University Hospital, Bordeaux; University Hospital, Bordeaux
Recruiting - verified December 2011 - Condition: Asthma
Interventions: Other: Educational game; Other: Educational game + motivational interview; Other: Motivational interview
Sponsors: Seattle Children's Hospital; Seattle Children's Hospital
Recruiting - verified July 2011 - Conditions: Asthma; Diabetes; Obesity; Premature Birth; Autistic Disorder
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified February 2012 - Conditions: Asthma; Copd
Intervention:
Sponsors: University Medical Centre Groningen; University Medical Centre Groningen
Recruiting - verified March 2012 - Condition: Asthma
Interventions: Biological: VSL#3; Biological: VSL#3 or placebo
Sponsors: University of Maryland; University of Maryland
Recruiting - verified March 2012 - Condition: Asthma
Intervention:
Sponsors: Ohio State University; Ohio State University
Recruiting - verified August 2011 - Condition: Asthma
Intervention:
Sponsors: Ohio State University; Ohio State University
Recruiting - verified July 2011 - Condition: Asthma
Intervention: Other: Exercise training
Sponsors: University Hospital, Strasbourg, France; University Hospital, Strasbourg, France
Recruiting - verified August 2011 - Condition: Asthma
Interventions: Drug: Levalbuterol; Drug: Levalbuterol UDV TID; Drug: Placebo
Sponsors: Sunovion; Sunovion
Recruiting - verified February 2012 - Conditions: Cystic Fibrosis; Bronchospasm
Intervention:
Sponsors: Ohio State University; Ohio State University
Recruiting - verified August 2011 - Condition: Asthma
Intervention: Biological: mepolizumab
Sponsors: University of Wisconsin, Madison; University of Wisconsin, Madison
Recruiting - verified August 2011 - Condition: Asthma
Intervention: Other: bronchoscopy
Sponsors: Imperial College London; Imperial College London; Asthma UK; Royal Brompton & Harefield NHS Foundation Trust
Recruiting - verified June 2011 - Condition: Asthma
Intervention: Drug: salmeterol
Sponsors: Nemours Children's Clinic; Nemours Children's Clinic; University of Florida
Recruiting - verified August 2011 - Conditions: Asthma; Allergies
Intervention:
Sponsors: Ohio State University; Ohio State University
Recruiting - verified August 2011 - Condition: Severe Persistent Asthma
Interventions: Drug: Lovastatin; Drug: Placebo
Sponsors: University of Chicago; University of Chicago
Not yet recruiting - verified August 2011 - Condition: Asthma
Intervention: Other: Fiberoptic bronchoscopy; blood test
Sponsors: Imperial College London; Imperial College London; Royal Brompton & Harefield NHS Foundation Trust; Medical Research Council
Recruiting - verified June 2011 - Condition: Asthma
Intervention: Drug: prednisolone
Sponsors: Imperial College London; Imperial College London; Royal Brompton & Harefield NHS Foundation Trust
Recruiting - verified June 2011 - Condition: Asthma
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified December 2011 - Condition: Asthma
Intervention: Procedure: allergen challenge
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital
Recruiting - verified December 2011 - Condition: Asthma
Intervention:
Sponsors: University of California, San Francisco; University of California, San Francisco
Recruiting - verified September 2011 - Condition: Asthma
Intervention: Device: CPAP-Continuous Positive Airway Pressure
Sponsors: Indiana University; Indiana University
Recruiting - verified March 2012 - Conditions: Asthma; Cystic Fibrosis; Smokers
Intervention:
Sponsors: University of California, San Francisco; University of California, San Francisco
Recruiting - verified September 2011 - Condition: Asthma
Interventions: Drug: budesonide/formoterol or fluticasone/salmeterol; Drug: budesonide/formoterol or fluticasone/salmeterol
Sponsors: Gelb, Arthur F., M.D.; Gelb, Arthur F., M.D.
Recruiting - verified March 2012 - Conditions: Asthma; Inflammation
Intervention:
Sponsors: National Institute of Environmental Health Sciences (NIEHS); National Institute of Environmental Health Sciences (NIEHS)
Recruiting - verified August 2008 - Condition: Inflammatory Disorder
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2012 - Condition: Asthma
Interventions: Drug: tiotropium; Drug: long acting beta agonist
Sponsors: University of Alberta; University of Alberta; Boehringer Ingelheim Pharmaceuticals
Recruiting - verified July 2011 - Condition: Asthma
Interventions: Dietary Supplement: Grapefruit juice; Dietary Supplement: Orange Juice; Dietary Supplement: Gatorade
Sponsors: Nemours Children's Clinic; Nemours Children's Clinic; Merck
Recruiting - verified November 2011 - Conditions: Asthma; COPD; Interstitial Lung Disease; Cystic Fibrosis; Lung Cancer
Intervention:
Sponsors: Weill Medical College of Cornell University; Weill Medical College of Cornell University; Weill Cornell Medical College in Qatar; Hamad Medical Corporation
Recruiting - verified August 2011 - Condition: Asthma
Intervention:
Sponsors: St. Olavs Hospital; St. Olavs Hospital; Haukeland University Hospital
Recruiting - verified December 2011 - Conditions: COPD; Congestive Heart Failure; Asthma; Respiratory Distress Syndrome, Adult; Pneumonia
Intervention:
Sponsors: Tufts Medical Center; Tufts Medical Center
Recruiting - verified July 2011 - Conditions: Asthma; COPD
Intervention: Drug: salbutamol
Sponsors: University of Saskatchewan; University of Saskatchewan
Recruiting - verified May 2012 - Conditions: Premature Birth; Bronchopulmonary Dysplasia; Asthma
Intervention:
Sponsors: Indiana University; Indiana University School of Medicine
Recruiting - verified March 2012 - Conditions: Infant, Premature; Bronchopulmonary Dysplasia; Asthma
Intervention:
Sponsors: Indiana University; Indiana University School of Medicine; National Institutes of Health (NIH)
Recruiting - verified March 2012 - Conditions: Pulmonary Disease; Oropharyngeal Disease; Lymphangioleiomyomatosis; Pulmonary Fibrosis; Asthma; Sarcoidosis
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified February 2012 - Conditions: Asthma; COPD; Interstitial Lung Disease; Cystic Fibrosis; Lung Cancer
Intervention:
Sponsors: Weill Medical College of Cornell University; Weill Medical College of Cornell University
Recruiting - verified August 2011 - Condition: Mild Asthma
Intervention: Drug: ozone
Sponsors: University of North Carolina, Chapel Hill; University of North Carolina, Chapel Hill; Environmental Protection Agency (EPA)
Recruiting - verified July 2011 - Condition: Asthma
Intervention:
Sponsors: New York University School of Medicine; New York University School of Medicine
Recruiting - verified November 2006 - Conditions: Lung Disease; Bronchitis; Emphysema; COPD; Asthma
Interventions: Procedure: Bronchopulmonary Lung Lavage; Procedure: Bronchial Brushing; Procedure: Bronchial Wall Biopsy
Sponsors: Weill Medical College of Cornell University; Weill Medical College of Cornell University
Recruiting - verified August 2011 - Condition: Asthma
Interventions: Dietary Supplement: Probiotic; Dietary Supplement: Placebo
Sponsors: University of California, San Francisco; University of California, San Francisco; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified March 2012 - Conditions: Asthma; Healthy
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified October 2011 - Conditions: Cystic Fibrosis; Sarcoidosis; Tuberous Sclerosis; Asthma
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified November 2011 - Conditions: Asthma; Eosinophilia; Helminthiasis; Hypersensitivity; Parasitic Disease
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified October 2011 - Conditions: Asthma; Pulmonary Fibrosis
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified March 2012
 |
Join Clinical Trials that Study Asthma, and other Respiratory Disorders |
